홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Triethylsilane → HCID 56974282, 화합물

HRID 1417557
노트
인쇄 미리보기

반응식

HRID 1417557 반응식
C([SiH](CC)CC)C.[CH3:8][O:9][C:10]([C@H:12]1[CH2:37][CH2:36][C@:14]2([O:18][CH:17]=[C:16]([C:19]3[CH:24]=[C:23]([N:25]4[CH:29]=[CH:28][N:27]=[C:26]4[C:30]([F:33])([F:32])[F:31])[CH:22]=[CH:21][C:20]=3[O:34][CH3:35])[CH2:15]2)[C@@H:13]1[C:38]1[CH:43]=[CH:42][C:41]([F:44])=[CH:40][CH:39]=1)=[O:11]>FC(F)(F)C(O)=O>[CH3:8][O:9][C:10]([C@H:12]1[CH2:37][CH2:36][C@:14]2([O:18][CH2:17][C@H:16]([C:19]3[CH:24]=[C:23]([N:25]4[CH:29]=[CH:28][N:27]=[C:26]4[C:30]([F:31])([F:32])[F:33])[CH:22]=[CH:21][C:20]=3[O:34][CH3:35])[CH2:15]2)[C@@H:13]1[C:38]1[CH:39]=[CH:40][C:41]([F:44])=[CH:42][CH:43]=1)=[O:11].[CH3:8][O:9][C:10]([C@H:12]1[CH2:37][CH2:36][C@:14]2([O:18][CH2:17][C@@H:16]([C:19]3[CH:24]=[C:23]([N:25]4[CH:29]=[CH:28][N:27]=[C:26]4[C:30]([F:31])([F:32])[F:33])[CH:22]=[CH:21][C:20]=3[O:34][CH3:35])[CH2:15]2)[C@@H:13]1[C:38]1[CH:39]=[CH:40][C:41]([F:44])=[CH:42][CH:43]=1)=[O:11]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 2

HCID 12052TriethylsilaneHCID 67670838HCID 67670838, 화합물

생성물 2

HCID 56974282HCID 56974282, 화합물HCID 67670401HCID 67670401, 화합물

시약·촉매·용매 1

HCID 6422Trifluoroacetic acid용매

실험 절차

Triethylsilane (0.0062 mL, 4.5 mg, 0.039 mmol) was added to a solution of (5R,6S,7S)-6-(4-fluorophenyl)-3-(2-methoxy-5-(2-(trifluoromethyl)imidazol-1-yl)phenyl)-1-oxaspiro[4.4]non-2-ene-7-carboxylic acid methyl ester (6.8 mg, 0.013 mmol) in 0.204 mL of trifluoroacetic acid at RT. The mixture was stirred 1 h at RT, then overnight at 60° C. After removing the solvent under reduced pressure, the residue was dissolved in 3.0 mL of ethyl acetate, washed with 2.0 mL of saturated aqueous sodium bicarbonate, dried over sodium sulfate and evaporated. The crude product was purified by preparative TLC, eluting twice with 3% ethyl ether in dichloromethane, to give 1.0 mg of (3S,5R,6S,7S)-6-(4-fluorophenyl)-3-(2-methoxy-5-(2-(trifluoromethyl)imidazol-1-yl)phenyl)-1-oxaspiro[4.4]nonane-7-carboxylic acid methyl ester and 2.6 mg of the title compound. 1NMR (400 MHz, CDCl3): δ 7.37 (dd, 2H, J=9, 6 Hz ), 7.19 (d, 1H, J=1 Hz), 7.15 (dd, 1H, J=9, 3 Hz ), 7.09 (d, 1H, J=2 Hz ), 7.08 (d, 1H, J=1 Hz ), 7.03 (t, 2H, J=9 Hz ), 6.82 (1H, J=9 Hz ), 3.78 (s, 3H), 3.70 (t, 1H, J=8 Hz ), 3.62 (t, 1H, J=8 Hz ), 3.56 (s, 3H), 3.14 (ddd, 1H, J=11, 10, 7 Hz ), 3.12 (d, 1H, J=11 Hz ), 2.87 (quintet, 1H, J=8 Hz ), 2.33-2.23 (m, 2H), 2.08-1.88 (m, 4H). Mass spectrum (ESI): m/z=519 (M+1).

후처리

  1. customovernight
  2. customat 60° C
  3. customAfter removing the solvent under reduced pressure
  4. dissolutionthe residue was dissolved in 3.0 mL of ethyl acetate
  5. washwashed with 2.0 mL of saturated aqueous sodium bicarbonate
  6. dry with materialdried over sodium sulfate
  7. customevaporated
  8. customThe crude product was purified by preparative TLC
  9. washeluting twice with 3% ethyl ether in dichloromethane

출처 및 근거

ORD 기록
ord-cb7fdc7d2abc400eba347b001ab32efa
출처 데이터셋
uspto-grants-1999_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US05877191

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트